We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

18 hedge funds and large institutions have $36.2M invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
–
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GL
Governors Lane
New York
+$7.63M
2
6CM
683 Capital Management
New York
+$7.39M
3
SRCM
Sage Rock Capital Management
New York
+$3.44M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.17M
5
CCM
Context Capital Management
California
+$2.85M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GL
1
Governors Lane
New York
$7.56M +$7.63M +723,104 New
6CM
2
683 Capital Management
New York
$7.32M +$7.39M +700,000 New
SRCM
3
Sage Rock Capital Management
New York
$3.41M +$3.44M +326,067 New
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$3.13M +$3.17M +300,000 New
CCM
5
Context Capital Management
California
$2.82M +$2.85M +270,000 New
CPF
6
Context Partners Fund
California
$2.82M +$2.85M +270,000 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$2.26M +$2.28M +216,453 New
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$1.61M +$1.62M +153,984 New
SCM
9
Suvretta Capital Management
New York
$1.57M +$1.58M +150,000 New
CCA
10
Castle Creek Arbitrage
Colorado
$1.54M +$1.55M +147,156 New
LA
11
Linden Advisors
New York
$419K +$422K +40,000 New
AA
12
AQR Arbitrage
Connecticut
$418K +$422K +39,999 New
DCM
13
Dupont Capital Management
Delaware
$418K +$422K +39,999 New
Verition Fund Management
14
Verition Fund Management
Connecticut
$308K +$311K +29,501 New
WAM
15
Wolverine Asset Management
Illinois
$276K +$279K +26,470 New
CAC
16
Cowen and Company
New York
$146K +$148K +14,000 New
Creative Planning
17
Creative Planning
Kansas
$140K +$141K +13,400 New
FIA
18
FNY Investment Advisers
New York
$53K +$54.5K +5,166 New

CERE Hedge Fund Activity: Q3 2020 in Review

18 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2020, worth a combined $36.2M.

Buyers outnumbered sellers: 18 funds opened new CERE positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Governors Lane, opening a new position worth an estimated $7.63M.

  • 18 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $36.2M of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2020.
  • 18 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2020 and 0 closed out, a net change of +18 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2020 was Governors Lane, an estimated $7.63M added.

Based on aggregated 13F filings for Q3 2020.